Giordano A, Lin NU, Tolaney SM, Mayer EL, et al. Is there a role for continuation of CDK4/6 inhibition after progression on a prior CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer? Ann Oncol 2023 Nov 10:S0923-7534(23)05062-7. doi: 10.1016/j.annonc.2023.
PMID: 37952893